68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

被引：160
作者：
Rauscher, Isabel [1 ,2 ,3 ]
Maurer, Tobias [2 ,4 ]
Fendler, Wolfgang P. [2 ,5 ]
Sommer, Wieland H. [2 ,6 ]
Schwaiger, Markus [1 ,2 ,3 ]
Eiber, Matthias [1 ,2 ,3 ]
机构：
[1] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[2] Clin Canc Ctr Munich CCM, Munich, Germany
[3] German Canc Consortium DKTK, Heidelberg, Germany
[4] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[5] Univ Munich, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[6] Univ Munich, Dept Clin Radiol, Grosshadern Campus,Marchioninistr 15, D-81377 Munich, Germany
来源：
CANCER IMAGING | 2016年 / 16卷
关键词：
Prostate cancer; Prostate specific membrane antigen; Positron emission tomography; GA-68-LABELED PSMA LIGAND; MEMBRANE ANTIGEN; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; LYMPH-NODES; HBED-CC; DIAGNOSIS; EXPRESSION; CARCINOMA; TOMOGRAPHY;
D O I：
10.1186/s40644-016-0072-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate cancer (PC). Several studies promise accurate staging of primary prostate cancer and restaging after biochemical recurrence with Ga-68-PSMA ligand Positron emission tomography/computed tomography (PET/CT). However, prospective trials and clinical guidelines for this new technique are still missing. Therefore, we summarized our experience with Ga-68-PSMA ligand PET/CT examinations in patients with primary PC and biochemical recurrence. It focuses on the technical and logistical aspects of Ga-68-PSMA ligand PET/CT examination as well as on the specific background for image reading discussing also potential pitfalls. Further, it includes relevant issues on free-text as well as structured reporting used in daily clinical routine.
引用
收藏
页数：10
相关论文
共 51 条
[11]   FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 [J].
Boellaard, Ronald ;
Delgado-Bolton, Roberto ;
Oyen, Wim J. G. ;
Giammarile, Francesco ;
Tatsch, Klaus ;
Eschner, Wolfgang ;
Verzijlbergen, Fred J. ;
Barrington, Sally F. ;
Pike, Lucy C. ;
Weber, Wolfgang A. ;
Stroobants, Sigrid ;
Delbeke, Dominique ;
Donohoe, Kevin J. ;
Holbrook, Scott ;
Graham, Michael M. ;
Testanera, Giorgio ;
Hoekstra, Otto S. ;
Zijlstra, Josee ;
Visser, Eric ;
Hoekstra, Corneline J. ;
Pruim, Jan ;
Willemsen, Antoon ;
Arends, Bertjan ;
Kotzerke, Joerg ;
Bockisch, Andreas ;
Beyer, Thomas ;
Chiti, Arturo ;
Krause, Bernd J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) :328-354
[12]  
Bosmans JML, 2015, INSIGHTS IMAGING, V6, P129, DOI 10.1007/s13244-014-0368-7
[13]   Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node Dissection [J].
Briganti, Alberto ;
Abdollah, Firas ;
Nini, Alessandro ;
Suardi, Nazareno ;
Gallina, Andrea ;
Capitanio, Umberto ;
Bianchi, Marco ;
Tutolo, Manuela ;
Passoni, Niccolo Maria ;
Salonia, Andrea ;
Colombo, Renzo ;
Freschi, Massimo ;
Rigatti, Patrizio ;
Montorsi, Francesco .
EUROPEAN UROLOGY, 2012, 61 (06) :1132-1138
[14]   Structured Reporting of Multiphasic CT for Pancreatic Cancer: Potential Effect on Staging and Surgical Planning [J].
Brook, Olga R. ;
Brook, Alexander ;
Vollmer, Charles M. ;
Kent, Tara S. ;
Sanchez, Norberto ;
Pedrosa, Ivan .
RADIOLOGY, 2015, 274 (02) :464-472
[15]   11C-Choline PET/CT and PSA kinetics [J].
Castellucci, Paolo ;
Picchio, Maria .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 :S36-S40
[16]   A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy [J].
Chism, DB ;
Hanlon, AL ;
Horwitz, EM ;
Feigenberg, SJ ;
Pollack, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02) :380-385
[17]   Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer [J].
Cho, Steve Y. ;
Gage, Kenneth L. ;
Mease, Ronnie C. ;
Senthamizhchelvan, Srinivasan ;
Holt, Daniel P. ;
Jeffrey-Kwanisai, Akimosa ;
Endres, Christopher J. ;
Dannals, Robert F. ;
Sgouros, George ;
Lodge, Martin ;
Eisenberger, Mario A. ;
Rodriguez, Ronald ;
Carducci, Michael A. ;
Rojas, Camilo ;
Slusher, Barbara S. ;
Kozikowski, Alan P. ;
Pomper, Martin G. .
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (12) :1883-1891
[18]  
Douglas PS, 2009, CIRCULATION, V119, P187, DOI 10.1161/CIRCULATIONAHA.108.191365
[19]   68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging [J].
Eder, Matthias ;
Schaefer, Martin ;
Bauder-Wuest, Ulrike ;
Hull, William-Edmund ;
Waengler, Carmen ;
Mier, Walter ;
Haberkorn, Uwe ;
Eisenhut, Michael .
BIOCONJUGATE CHEMISTRY, 2012, 23 (04) :688-697
[20]   Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy [J].
Eiber, Matthias ;
Maurer, Tobias ;
Souvatzoglou, Michael ;
Beer, Ambros J. ;
Ruffani, Alexander ;
Haller, Bernhard ;
Graner, Frank-Philipp ;
Kuebler, Hubert ;
Haberhorn, Uwe ;
Eisenhut, Michael ;
Wester, Hans-Juergen ;
Gschwend, Juergen E. ;
Schwaiger, Markus .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (05) :668-674
123456